Copenhagen Oe

• A study to learn BAY 3498264 when given alone or together with sotorasib in participants who have advanced solid cancers with specific genet … Recruiting
  2024-513300-34-00 1 2024-11-18 Advanced solid tumors harboring KRAS G12C mutation
• Bomedemstat vs Hydroxyurea for Essential Thrombocythemia Recruiting
  2023-505232-36-00 5 2024-11-15 Essential thrombocythemia
• A first-in-human study of PARP1 selective inhibitor, IMP1734, in patients with advanced solid tumors. Recruiting
  2023-509230-19-00 7 2024-11-14 Advance solid tumors
• LIGHTBEAM-U01-Substudy 01A: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Zilovertamab Vedotin in Pediatric and Young Adult Pa … Recruiting
  2023-507178-41-00 9 2024-11-07 Hematologic Malignancies or Solid Tumors in Pediatric and Young Adults
• GSDIa Disease Monitoring Program Recruiting
  2023-510219-20-00 11 2024-11-04 Glycogen storage disease type Ia (GSDIa)
• A study to learn more about how well sevabertinib works and how safe it is compared with standard treatment, in participants who have advanc … Recruiting
  2024-511319-91-00 5 2024-10-23 Advanced non-small cell lung cancer with HER2 (ERBB2) mutation
• New Beacon Recruiting
  2024-518419-20-00 4 2024-10-23 BRAF V600E mutated colorectal cancer
• FAST TRIAL Recruiting
  2024-515507-18-00 5 2024-10-09 Status epilepticus
• A study to test the efficacy and safety of riliprubart against the usual treatment of intravenous immunoglobulin (IVIg) in people with chron … Recruiting
  2023-508338-33-00 5 2024-10-01 Chronic Inflammatory Demyelinating Polyneuropathy
• A Study to Evaluate ARV-393 in Adult Participants with Advanced Non-Hodgkin’s Lymphoma Recruiting
  2023-510136-36-00 1 2024-09-27 Advanced Non-Hodgkin’s Lymphoma
• A randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy, safety, and tolerability of iptacopan in patients w … Recruiting
  2023-507064-39-00 5 2024-09-26 generalized Myasthenia Gravis
• VEX-AZA: Treating VEXAS Syndrome with Azacitidine. A Single-Arm, Multicenter Phase II Study on the Efficacy and Safety of Azacitidine in Pat … Recruiting
  2024-510715-30-00 4 2024-09-26 VEXAS
• Local Antibiotics for Women Undergoing Breast Reconstruction Surgery with Implants Recruiting
  2024-517672-38-00 5 2024-09-20 Infection
• Semaglutide Treatment for Prevention of Toxicity in High-dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation Recruiting
  2022-502139-20-00 4 2024-09-09 Mucositis and systemical inflammation, which is a treatment-related co
• Safety and efficacy of oral semaglutide in hyperglycaemic patients after renal transplantation Recruiting
  2023-504159-29-01 4 2024-09-03 Hyperglycaemia after renal transplantation
• The Neurobiological Effect of 5-HT2AR Modulation Recruiting
  2024-515961-33-00 3 2024-09-02 No medical conditions or diseases will be examined, only healthy volun
• PHASE II STUDY OF AZACITIDINE IN COMBINATION WITH LOW DOSE INTENSITY VENETOCLAX IN PATIENTS WITH ACUTE MYELOID LEUKEMIA WITH INTEGRATION OF … Recruiting
  2023-510415-19-00 4 2024-08-28 Acute Myeloid Leukemia
• IDEAL-COR Recruiting
  2023-505270-15-00 11 2024-08-19 Overweight and obesity
• Pericapsular nerve group (PENG) block for postoperative pain after peri-acetabular osteotomy Recruiting
  2024-513688-25-01 6 2024-08-19 periacetabular osteotomy
• A study to test the effects and safety of riliprubart in people with chronic inflammatory demyelinating polyneuropathy (CIDP) for which the … Recruiting
  2023-506503-26-00 5 2024-07-31 Polyneuropathy, Inflammatory Demyelinating, Chronic
• HEMODIALYSIS AND ANTIBIOTIC PROPHYLAXIS Recruiting
  2024-515001-26-00 6 2024-07-25 Blood poisoning in patients with renal failure treated with hemodialys
• A study comparing TAR-210 versus single agent treatment instilled directly into the bladder in people with bladder cancer with FGFR gene alt … Recruiting
  2023-507684-19-00 5 2024-07-24 FGFR+ Intermediate-risk Non-muscle Invasive Bladder Cancer
• New treatments to reduce cardiovascular disease in type 1 diabetes Recruiting
  2023-505794-32-04 5 2024-07-05 Type 1 diabetes
• Intrapleural Fibrinolysis and DNase versus VATS for the treatment of pleural empyema: a randomized, controlled trial Recruiting
  2024-513596-40-00 6 2024-06-28 Pleural empyema

Showing 241–264 of 671 trials